BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6197106)

  • 1. Individualization of gamma globulin dosage in patients with humoral immunodeficiency.
    Schiff RI; Rudd C; Johnson R; Buckley RH
    Birth Defects Orig Artic Ser; 1983; 19(3):209-12. PubMed ID: 6197106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of serum immunoglobulins during and after intravenous administration of gamma globulin in subjects with antibody deficiency syndromes].
    Gravina E; Gravina-Sanvitale G
    Minerva Pediatr; 1975 Jun; 27(20):1166-70. PubMed ID: 49009
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease.
    Cunningham-Rundles C; Smithwick EM; Siegal FP; Day NK; Lion A; O'Malley J; Barandun S; Good RA
    Birth Defects Orig Artic Ser; 1983; 19(3):201-3. PubMed ID: 6197105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intravenous gamma globulin therapy in Bruton's antibody deficiency syndrome].
    Rossipal E
    Wien Med Wochenschr; 1978 Apr; 128(8):240-3. PubMed ID: 77587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Case of A-G dysgammaglobulinemia].
    Lama G; Torino G
    Pediatria (Napoli); 1974 Mar; 82(1):117-26. PubMed ID: 4136311
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunoglobulin A deficiency treated with gamma A globulin].
    Horanský V; Horanská M
    Cesk Pediatr; 1973 Feb; 28(2):73-5. PubMed ID: 4119696
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to phosphorylcholine in sera of patients with humoral immunodeficiency disease.
    Cunningham-Rundles C
    Monogr Allergy; 1986; 20():43-9. PubMed ID: 3773911
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease.
    Cunningham-Rundles C; Siegal FP; Smithwick EM; Lion-Boulé A; Cunningham-Rundles S; O'Malley J; Barandun S; Good RA
    Ann Intern Med; 1984 Oct; 101(4):435-9. PubMed ID: 6206756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of primary immunodeficiencies with intravenous gamma globulin].
    García Rodríguez C; López Trascasa M; Ferreira Cerdán A; Fontán Casariego G
    An Esp Pediatr; 1987 Dec; 27(6):411-5. PubMed ID: 2451892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin therapy for antibody deficiency.
    Nolte MT; Pirofsky B; Gerritz GA; Golding B
    Clin Exp Immunol; 1979 May; 36(2):237-43. PubMed ID: 477026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy with immunoglobulins with special regard to the problem of the efficacy of intravenously applied gammaglobulin in bacterial infections].
    Duswald KH; Ring J
    Klin Anasthesiol Intensivther; 1980; 21():207-23. PubMed ID: 6161270
    [No Abstract]   [Full Text] [Related]  

  • 12. The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin.
    Mankarious S; Lee M; Fischer S; Pyun KH; Ochs HD; Oxelius VA; Wedgwood RJ
    J Lab Clin Med; 1988 Nov; 112(5):634-40. PubMed ID: 3183495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the half-life and clearance of IgG during therapy with intravenous gamma-globulin in 16 patients with severe primary humoral immunodeficiency.
    Schiff RI; Rudd C
    J Clin Immunol; 1986 May; 6(3):256-64. PubMed ID: 2424931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of congenital immune deficiencies by parenteral gammaglobulins].
    Buriot D; Eygonnet JP; Jeannel-Boiteux F; Griscelli C
    Pediatrie; 1981 Jun; 36(4):253-61. PubMed ID: 6170044
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correction of secondary immunodeficiency with antilymphocyte sera and gamma globulins].
    Antonenko VT; Timchenko AS; Skuratovskiĭ MF; Bondar' MV; Podrushniak EP
    Vrach Delo; 1983 Sep; (9):72-5. PubMed ID: 6196917
    [No Abstract]   [Full Text] [Related]  

  • 16. Individualizing the dose of intravenous immune serum globulin for therapy of patients with primary humoral immunodeficiency.
    Schiff RI
    Vox Sang; 1985; 49 Suppl 1():15-24. PubMed ID: 2416124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutical application of gammaglobulin preparations in inborn immunodeficiency syndromes (author's transl)].
    Mietens C
    Immun Infekt; 1981 Sep; 9(5):170-4. PubMed ID: 6170572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency.
    Gardulf A; Björvell H; Gustafson R; Hammarström L; Smith CI
    Immunodeficiency; 1993; 4(1-4):81-4. PubMed ID: 7513227
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects and side effects of intravenous gamma globulin I: the problem of immune complex formation].
    Tilz GP; Nydegger U
    Wien Med Wochenschr; 1991; 141(13):301-3. PubMed ID: 1926879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of defects of humoral immunity.
    Eibl M
    Birth Defects Orig Artic Ser; 1983; 19(3):193-200. PubMed ID: 6228269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.